Aquestive Therapeutics Inc (NASDAQ:AQST) currently has a daily average trading volume of 1.51M but it saw 1249415 shares traded in last market. With a market cap of 328.78M USD, the company’s current market price of $3.31 came falling about -2.93 while comparing to the previous closing price of $3.41. In past 52 weeks, the stock remained buoying in the range of price level as high as $5.80 and as low as $2.12. In the recent trading on the day, stock has struck highest price mark of $3.2003 while lowest mark touched by it was $3.395.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Oppenheimer which resumed the stock as “Outperform” in its note to investors issued on June 02, 2025, recommending a price target of $7 for it. Leerink Partners issued its recommendations for the stock as it initiated the price target for the stock is $8.
Over the week, AQST’s stock price is moving -7.28% down while it is 44.54% when we observe its performance for the past one month. Year-to-date it is -7.02% down and over the past year, the stock is showing an upside performance of 19.93%.
Currently, Aquestive Therapeutics Inc’s total number of outstanding shares is 99.32M with 5.56% of that held by the insiders while 48.86% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -87.52%. Stock’s beta reads 1.94. Stock has a price to sale or P/S ratio amounts to 6.06. Its return on asset (ROA) is -46.81% on average.
